Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its Bloomington, Indiana, production facility, which contributes to the blockbuster GLP-1 medications Ozempic and Wegovy.
Novo Nordisk cuts 400 roles at troubled Bloomington site
Latest from Blog
STAT+: Can a psychedelic ‘coach’ make ketamine therapy even more effective?
Ketamine treatment clinics have proliferated following the Food and Drug Administration’s approval of the drug as a remedy for acute depression in 2019, leading to a Wild West of infusion clinics that
Why an ovary syndrome may get a new name: Men seem to have PCOS, too
Few things will give a man as much of an insight into the female body as growing up with sisters. Painful, irregular periods, body hair, skin trouble: Al Barrus, a 43-year-old veteran
The Human Side of AI Medical Devices: Why Safety Depends on Design, Not Just Algorithms
As artificial intelligence becomes increasingly embedded in medical devices, most discussions focus on algorithm performance metrics such as accuracy and robustness. However, many real-world safety risks arise not from the model itself
Nutrition program brings healthier options to student-athletes in Birmingham schools
A nutrition program at Huffman High School is changing the way student-athletes think about food. Post Views: 2
Newtown C.H.A.T. group collboates to move nutrition into daily discussions
WWSB Empowering Voices – Saturday at 10am Post Views: 2